TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹319 Cr | ₹30 Cr | ₹-175 Cr | ₹-95 Cr | ₹42 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹319 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹-175 Cr |
Mar2021 | ₹-95 Cr |
Mar2020 | ₹42 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹319 Cr | 955.47 | |
Mar2023 | ₹30 Cr | Positive | |
Mar2022 | ₹-175 Cr | Negative | |
Mar2021 | ₹-95 Cr | Negative | |
Mar2020 | ₹42 Cr | - |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹110,941.1 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 2.3% |
-0.5% |
13.8% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses